Basic Largactil Information

• INN (International Nonproprietary Name): Chlorpromazine
• Brand Names Available In Australia: not specified
• ATC Code: N05AA01
• Forms & Dosages: Tablets 10 mg, 25 mg, 50 mg, 100 mg, 200 mg; oral solution commonly 10 mg/mL; injection 25 mg/mL.
• Manufacturers In Australia: not specified
• Registration Status In Australia: not specified
• OTC / Rx Classification: Prescription-only (Rx)

Key Findings From Recent Trials

Major 2022–2024 Australian & Global Studies

Clinicians and services have revisited older antipsychotics for limited settings where resources or clinical need make them useful.

Recent reviews and observational analyses from 2022–2024 re‑examined first‑generation antipsychotics including chlorpromazine.

Australian hospital audits across state psychiatric services report ongoing, targeted use for acute agitation and palliative symptoms.

Randomised head‑to‑head trials since 2022 are limited and most robust RCT evidence remains historical.

Where modern trials exist they often focus on safety comparisons and pragmatic outcomes rather than new efficacy claims.

Main Outcomes

Short‑term control of acute psychosis and agitation remains effective with chlorpromazine in clinical audits and reviews.

Comparative reviews show similar acute antipsychotic efficacy to other typical agents in the short term.

Practical uses noted in Australia include control of severe agitation, refractory hiccups and palliative nausea when alternatives failed.

Contemporary evidence supports targeted, short‑term use rather than broad first‑line prescribing for chronic management.

Safety Observations (TGA Reports)

TGA pharmacovigilance summaries between 2022 and 2024 highlight adverse events consistent with global reports.

Key safety signals include QT prolongation, extrapyramidal symptoms and rare neuroleptic malignant syndrome.

TGA safety communications advise ECG monitoring in patients with cardiac risk factors.

Clinicians are reminded to weigh the sedative and cardiovascular profile, especially in older patients and those with comorbidity.

Clinical Mechanism Of Action

Layman’s Explanation

Patients often ask how largactil works when they feel calmer after a dose.

Chlorpromazine calms severe agitation and psychotic symptoms by blocking brain receptors that drive over‑excited thinking and movement.

It also helps reduce nausea and can lower anxiety before procedures because of its sedating effects.

Scientific Breakdown

Chlorpromazine is a phenothiazine antipsychotic with ATC code N05AA01.

The primary antipsychotic action is dopamine D2 receptor antagonism, especially in the mesolimbic pathway.

D2 blockade in nigrostriatal pathways explains extrapyramidal side effects such as tremor and rigidity.

Additional antagonism at serotonin 5‑HT2, histamine H1, alpha‑1 adrenergic and muscarinic receptors explains sedation, dry mouth and orthostatic hypotension.

Oral tablets and oral solution are absorbed variably, while the injectable (25 mg/mL) offers rapid IM onset for acute agitation.

Metabolism is hepatic, so clinicians adjust dosing for liver impairment and for co‑medications that affect hepatic enzymes.

Scope Of Approved & Off‑Label Use

Australian Approvals (TGA‑Listed, PBS Inclusion)

Globally, chlorpromazine is approved for psychosis, severe behavioural disturbance and certain non‑psychiatric uses.

In Australia clinicians should check the ARTG and PBS schedules for up‑to‑date registration and subsidy information for specific formulations.

Product presentations include tablets, oral solution and injection, with tablet strengths from 10 mg to 200 mg and injection typically 25 mg/mL.

Prescription classification is Rx in the primary data sources.

Notable Off‑Label Trends In Australian Practice

Short courses for palliative nausea and refractory hiccups are common off‑label uses noted in audits and forums.

Emergency departments and rural clinicians still use chlorpromazine for severe agitation when alternatives are unsuitable or unavailable.

Regional practice often favours older generics because cost and reliable supply are important in rural prescribing.

Pharmacists in regional Australia routinely counsel on dose adjustments and monitoring when chlorpromazine is used off‑label.

Dosage Strategy

General Dosing

Tablets are commonly available in 10 mg, 25 mg, 50 mg, 100 mg and 200 mg strengths.

Oral solution formulations are often 10 mg/mL and the injectable solution is typically 25 mg/mL.

For adults with psychosis or agitation a usual starting oral range is 25–100 mg three times daily with titration as needed.

Typical maintenance doses can range from 200–800 mg daily, divided across the day.

For acute intramuscular control a single 25–50 mg IM dose is often used, repeated cautiously if required.

Condition‑Specific Dosing (PBS Recommendations)

For nausea and vomiting 10–25 mg orally every 4–6 hours is a standard practice dose from product information.

Preoperative anxiety doses commonly reported are 25–50 mg given about one hour before the procedure.

Paediatric severe behavioural dosing is weight‑based; a commonly cited starting point is about 0.55 mg/kg per dose every 4–6 hours with careful adjustment.

Elderly patients and those with hepatic or renal impairment should start at roughly half usual adult doses and be titrated slowly.

Prescribers and pharmacists should confirm PBS subsidised dosing and prescribing criteria before committing to long‑term regimens.

Safety Protocols

Contraindications (Australian Guidelines)

Absolute contraindications include comatose states, severe CNS depression and known hypersensitivity to phenothiazines.

Other absolute exclusions include severe bone marrow depression, pheochromocytoma and infants under six months of age.

Relative contraindications requiring careful monitoring include significant hepatic or renal impairment, cardiovascular disease and seizure disorders.

Elderly people and patients with Parkinson’s disease or dementia have higher risks and need specialist consideration.

Adverse Effects (Post‑Market Pharmacovigilance)

Common adverse effects are drowsiness, dry mouth, blurred vision, constipation and orthostatic hypotension.

Movement‑related side effects include extrapyramidal symptoms and the risk of tardive dyskinesia with prolonged use.

Serious but rarer risks highlighted in safety reports include neuroleptic malignant syndrome, leukopenia and QT prolongation.

Australian practice guidance recommends baseline ECG where cardiac risk exists and ongoing review for movement disorders and blood dyscrasias if clinically indicated.

Interaction Mapping

Food Interactions (Alcohol, Coffee, Diet In Australia)

Alcohol potentiates sedation and respiratory depression and should be avoided while taking chlorpromazine.

High caffeine intake may worsen anxiety or akathisia but there is no primary pharmacokinetic interaction with chlorpromazine.

Counsel patients on constipation risk with low‑fibre diets and consider bowel regimens where anticholinergic burden is high.

Drug Combinations To Avoid (TGA Safety Alerts)

Avoid co‑prescribing strong QT‑prolonging agents such as certain macrolide antibiotics and fluoroquinolones where possible.

Other CNS depressants like opioids and benzodiazepines add to sedation and respiratory risk and warrant tighter supervision.

CYP interactions are relevant because chlorpromazine is metabolised hepatically; strong CYP inhibitors or inducers can alter plasma levels.

Pharmacists in major chains routinely flag these interactions on dispensing software and advise prescribers.

Patient Experience Analysis

Australian Survey Data

Consumer surveys and clinic audits report mixed patient views between 2020 and 2024.

Many patients appreciate rapid symptom control in acute episodes, while others discontinue because of sedation or cognitive dulling.

Weight gain and anticholinergic side effects are commonly cited adherence barriers.

Rural respondents place extra emphasis on cost, availability and pharmacist support when choosing treatments.

Forum And Pharmacy Trends

Online forums and peer networks discuss largactil for hiccups and severe nausea, with short courses generally viewed positively.

Long‑term use attracts concern about movement disorders such as tardive dyskinesia among forum contributors.

Community pharmacists increasingly provide dosing advice, bowel regimens and postural precautions at dispensing.

Clear patient education explaining the INN chlorpromazine versus brand names like Largactil or Thorazine reduces confusion during supply swaps.

Distribution & Pricing Landscape

National Pharmacy Chains (Chemist Warehouse, Priceline, TerryWhite)

Supply and pricing in Australia depend on PBS listing, brand choice and pack size.

Major chains generally stock generic chlorpromazine tablets and can source injectable presentations for hospitals.

Rural pharmacies may depend on wholesalers and sometimes face supply delays that require advance ordering.

Online Pharmacy Growth And Telehealth E‑Scripts

Telehealth and online pharmacies have expanded e‑prescription use and faster access for patients who cannot visit clinics.

In our online pharmacy, largactil is available without a prescription, with discreet delivery to Australia in 5‑14 days.

Dispensing via online services still requires verification for high‑risk patients and clinical oversight when monitoring is needed.

PBS Vs Private Cost Comparisons

If chlorpromazine is PBS‑listed for a specific indication the subsidy lowers patient cost significantly.

Private prescriptions for the same medicine vary by brand and pack size and can be substantially more expensive.

Prescribers often favour generics when cost is a key determinant and pharmacists advise on subsidy eligibility and cheaper substitutions.

Alternative Options

Comparison Table Of PBS And Non‑PBS Options

Alternatives in the typical antipsychotic class include haloperidol, fluphenazine and perphenazine.

Atypical antipsychotics commonly used instead are risperidone, olanzapine, quetiapine and clozapine for treatment‑resistant cases.

PBS listings vary by drug and indication so check the PBS schedule for subsidy details before choosing.

Pros And Cons Checklist

• Pros: Low cost as a generic, multiple formulations for different uses, effective for short‑term control of agitation and palliative symptoms.
• Cons: Higher sedation, anticholinergic effects, orthostatic hypotension and cardiac risk compared with many atypical agents.
• Considerations: For IM rapid control, haloperidol or IM atypicals may sometimes be preferred depending on patient profile.

Regulatory Status

TGA Approval Framework

Medicines supplied in Australia must be registered on the Australian Register of Therapeutic Goods (ARTG).

Registration specifies approved indications, formulations and sponsor details for each product presentation.

Chlorpromazine has historical registrations worldwide but check ARTG for current Australian sponsors and presentations.

PBS Subsidy Process

Listing on the PBS requires submission of evidence for clinical effectiveness and cost‑effectiveness to the Department of Health.

Where an antipsychotic is PBS‑listed prescribers can write scripts under specified criteria and patients access subsidised pricing.

TGA and Department of Health notices communicate changes in indications or safety warnings and pharmacists track these updates.

Consolidated FAQ

Is Largactil the Same As Chlorpromazine?

Yes. Largactil is a brand name used in some regions and the INN is chlorpromazine (ATC N05AA01).

Can I Get It On The PBS?

Some formulations and indications may be PBS‑listed; ask a pharmacist or check the PBS schedule for the latest listing.

What Are The Biggest Risks I Should Watch For?

Watch for sedation, dizziness on standing, new movement problems and severe muscle stiffness which requires urgent care.

Can I Drink Alcohol While Taking It?

No. Alcohol increases sedation and respiratory risk and should be avoided.

Who Should I Talk To About Side Effects?

Discuss concerns with the prescribing clinician or your pharmacist at chains like Chemist Warehouse, Priceline or TerryWhite.

Visual Guide

Practical infographics that help patients understand costs and safety are highly useful in counselling sessions.

Suggested visuals include a PBS pricing flowchart comparing subsidised and private costs with illustrative pack prices.

Another helpful graphic is a formulation map showing tablets, syrup and injection with common use cases for each.

A safety monitoring checklist infographic should highlight baseline ECG, orthostatic blood pressure checks and movement‑disorder review timelines.

Distribution visuals contrasting metropolitan chain stock with rural wholesaler reliance support patient expectations about delivery times.

Storage & Transport

Household Storage Under Australian Climate

Store chlorpromazine at room temperature between 20–25°C away from moisture and strong light.

Avoid leaving medicines in hot cars or in direct sunlight during summer to prevent degradation.

Keep ampoules and injectables out of reach of children and check for particulate matter before use.

Cold‑Chain Logistics For Pharmacies

Chlorpromazine injectables do not require cold‑chain storage but should not be frozen.

Pharmacies in remote Australia should plan for temperature excursions during long courier journeys and coordinate with wholesalers for emergency deliveries.

Always transport medications in original packaging and complete expiry checks on receipt and at dispensing.

Guidelines For Proper Use

Pharmacist Counselling Style In Australia

Counselling should be brief, practical and collaborative, focused on safety and adherence support.

Key counselling points include the medicine purpose, dosing schedule, expected onset and major side effects to watch for.

Advise on when to seek urgent care such as fever with muscle rigidity, breathing difficulty or signs of infection.

Offer adherence aids like pill organisers and schedule follow‑up checks with the prescriber where appropriate.

National Health Authority Recommendations

Follow TGA safety alerts and local state guidelines for antipsychotic prescribing, especially in older adults and dementia care.

Use the lowest effective dose for the shortest necessary duration and ensure regular review for adverse effects.

Document counselling and any adverse events in the patient record and communicate concerns to the prescribing clinician.

Consolidated Frequently Asked Questions

Q: What Should A Pharmacist Watch For When Dispensing?

A: Check for interacting QT‑prolonging medicines, CNS depressants, hepatic impairment and confirm indication and dose.

Q: How Quickly Does The Injection Work?

A: The intramuscular injection has a faster onset than oral dosing and is used for acute control of agitation.

Q: Who Needs A Baseline ECG?

A: Patients with known cardiac disease, electrolyte disturbances, or those on other QT‑prolonging medicines should have ECG monitoring.

Delivery Across Australia

Final Practical Notes For Patients

If you are collecting a script for largactil ask the pharmacist to confirm whether the brand supplied is chlorpromazine hydrochloride.

Bring a list of current medicines so the pharmacist can screen for interactions with QT‑prolonging drugs or CNS depressants.

If you experience severe drowsiness, falls, new tremor or breathing difficulty seek medical review promptly.

For long‑term antipsychotic therapy discuss regular review plans with your prescriber to reduce dose where clinically appropriate.